Loading...
Invesco Dynamic Biotechnology & Genome ETF
PBE•AMEX
Financial ServicesAsset Management
$61.73
$0.03(0.05%)
Invesco Dynamic Biotechnology & Genome ETF (PBE) Stock Overview
Explore Invesco Dynamic Biotechnology & Genome ETF’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for PBEStats details for PBE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for PBEAnalyst Recommendations details for PBE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Headquarters
Wheaton, MA
Founded
2005